LATE ABSTRACT SUBMISSION DEADLINE: 30 JULY
LATE REGISTRATION DEADLINE: 15 AUGUST

This annual meeting brings together 2,000 scientists working in the life sciences. It features an impressive line-up of more than 120 world-class scientific speakers, including: Elizabeth Blackburn (Nobel Laureate 2009), Richard Losick, Marc Vidal and Ron Weiss.

The program includes three plenary lecture sessions devoted to modern evolutionary biology, molecular developmental biology and the rapidly developing fields related to systems biology, such as functional genomics, network, and synthetic biology.

A rich selection of topics will be addressed in 21 workshops, juxtaposing classical fields of research with those exploring new frontiers in molecular biology.

Drug development is becoming more complex and also more and more expensive. Those involved with the process of developing new therapeutics must understand the process and be able to navigate it with great skill. Failure is incredibly expensive.

The Drug Development Boot Camp will provide experience of the drug development process using a variety of methods. This will be an intensive but fun learning experience for all involved. You will learn in two days what it would take years to learn. A mixture of large/small pharma, and expert panel members will ensure panel discussions are relevant, responsive and applicable to situations that participants face.

This conference will showcase more than 15 industry perspectives on the most effective scientific and strategic approaches to extend life-cycle management of drug products. Marcus Evans invites senior level executives from pharmaceutical, biotech, and medical device companies to take this opportunity to benchmark best practices with their industry peers in order to develop sound strategies for drug repositioning.

This online event will showcase some of the medical device industry's thought leaders as they deliver presentations on the key issues that face the medical devices industry across all product and therapeutic segments within the realm of market and patient access.

Due to the huge variety in products within the industry, each requires a specific set of considerations for it to gain market access, and this webinar will focus on addressing these considerations through presentations from highly experienced market access professionals from within the medical devices industry.

BioPharm America^™ is where biotech industry partnerships get started. Meet one-to-one with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE^™, the world's leading interactive partnering system for the life science industry, BioPharm America is the only event in North America based on the same proven formula as EBD Group's acclaimed European events BIO-Europe^* and BIO-Europe Spring^™. In addition to productive partnering, BioPharm America offers high level workshops, panels, company presentations and a lively exhibition.

BioPartnering Latin America^™ (BPL) will bring together professionals from all over the world, including the Latin American region from Mexico to Chile, Brazil, and Argentina. The focus of BPL will be life science, including human, animal and plant health and technology; highlighting the fast growing sector of innovative Latin American companies which will present significant partnering opportunities.

GTCbio's 5^th Assay and Drug Discovery Technologies Conference features a mixture of academic, industry and public sector experts in an intimate setting that favors the showcase of data, exchanges of ideas and networking. Professionals in the drug discovery industry and academics can get an update of exciting new developments in assay technologies and exchange ideas in developing creative approaches in the drug discovery and development process to improve the efficiency and output. Topics include cell based assays, in vitro assays, high content analysis, high throughput screening, assays for protein therapeutics and biomarker discoveries, label-free technologies, fragment based screening and more!

IQPC's 2nd Anti-Infectives Summit taking place September 27-29 in San Francisco, CA will continue the discovery of new and innovative drug candidates with a deliberate focus on one of the most promising growth areas, antiviral therapeutics. Begin to better build and manage your anti-infective drug portfolio upon hearing from The Anti-Infectives Summit body of experts.

Marcus evans invites senior level directors from leading pharmaceutical and biotech industries to join other leading companies in order to discuss optimizing drug discovery, research, & development through strategic & scientific external innovation networks at the Pharma External and Open Innovation Conference. This event will be bringing together the top practitioners from Pfizer, Johnson & Johnson, Eli Lilly, Novartis Pharmaceuticals R&D, Takeda Research Investments and many more to discuss the framework for an Open and External Innovation that will at the bottom line bring new and creative solutions to the field of medicine.

This conference will focus on the upstream phases of drug discovery. It will focus primarily on antibody engineering and antibody technologies rather than the production and downstream processing. It will also focus on tailoring mAbs for clinical utility, making them more patient-friendly and designing efficacious and potent antibody treatments from early on in the drug discovery function.

In attending this premier marcus evans conference you will gain a better understanding of the design, and execution needed for adaptive clinical trials from companies paving the way within the industry. Learn how to conduct effective adaptive trials through specialized workshops for both statisticians and clinicians. This conference is a unique benchmarking and learning experience on an emerging area of focus for clinical trials.

Now in its seventh year, GTCbio's upcoming Anti-Infectives Partnering and Deal Making-Summit is taking place on October 7^th – 8^th, 2010 in Boston, MA. This infectious disease partnering and business development conference gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations and learn about relevant anti-infective issues and deals.

This event also provides a unique venue for attendees to learn about the anti-infective business development trends, the infectious disease markets, and novel technologies that shape up the industry. Don't miss this exciting and informative event!

BioPartnering Europe^™ (BPE) Leading European life science partnering for 18 years.

BPE offers excellent partnering opportunities for the best and brightest in the life science industry. Three days of networking in 1 location to meet with decision-makers from leading biotechnology, pharmaceutical, and investment companies from around the world for face-to-face partnering meetings, presentations, expert panels, and exhibitions. Register for BPE and connect your company with The Global Life Science Network^™.

For more information and to register, visit: www.techvision.com/bpe/.

Partner. Present. Connect. Grow your business at AdvaMed 2010: The MedTech Conference. Educational Panels, Plenaries by FDA, commerce andmedia leaders. See the full conference program at www.AdvaMed2010.com. Register by August 20th and save up to $600. Questions? E-mail: Info@medtechconference.org.

Join your colleagues in an opportunity to network with over 125 leading industrial and academic experts at this three-day summit. The 6th Modern Drug Discovery and Development Summit in San Francisco, CA, on October 20^th – 22^nd, 2010 will offer an in-depth examination of the challenges involved in the dynamic and ever-changing field of drug discovery and development. Featuring keynote plenary sessions with leaders from Roche, Theravance, Human Genome Sciences, and Novartis, this summit will include four distinct tracks: the 4^th Biomarkers Discovery and Development, 2^nd Cancer Targets and Therapeutics, 4^th Advances in Stem Cell Discovery and Development, and 5^th Biological Therapeutics.

Now celebrating its fourth year, GTCbio's Biomarker Conference is one part of four distinct tracks in the 6^th Modern Drug Discovery and Development Summit! This three-day event brings together the top pharmaceutical leaders to discuss comprehensive perspectives on the past and present of biomarker research. Commencing with a plenary session featuring keynote speakers from Roche, Novartis, Theravance, and Human Genome Sciences, the conference also includes discussions on novel technologies, pre-clinical and clinical aspects of biomarker discovery and development, challenges associated with biomarkers, and more. Come network with some of the biggest names in biomarkers in this timely and informative conference.

As exciting new discoveries in cancer therapies emerge, GTCbio's 2^nd Cancer Targets and Therapeutics Conference discusses the latest in cancer research with some of the biggest names in the industry. The conference, part of the 6^th Modern Drug Discovery and Development Summit, brings together top pharmaceutical leaders in this three-day event, which includes a plenary keynote session with speakers from Theravance, Roche, Human Genome Sciences, and Novartis. Presentations include discussions in immunotherapies, cancer vaccines, stem cells, kinase targets, inhibitors and much more. Come join your colleagues and network with top names and hear informative discussions in cancer targets and therapeutics.

With the lift of the federal ban on stem cell research, exciting opportunities and funding sources will arise. GTCbio's 4th Advances in Stem Cell Discovery and Development Conference on 20^th – 22^nd, 2010 in San Francisco, CA presents its attendants with information regarding cutting-edge developments in all areas of stem cell research, including a keynote plenary session with leaders from Human Genome Sciences, Theravance, Roche, and Novartis. Discussions will cover biology, applications, regulations, pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, FDA and NIH funding policies, and private funding from the pharmaceutical industry.

Research in biologics has become a hot area for many large pharmaceutical companies as expiring patents, a flood of generic drugs and slowing growth in small-molecule drug pipelines have led to decreasing revenues. GTCbio's 5^th Biological Therapeutics Conference provides participants with a current look at biologics and future projects with discussions regarding developments in drug delivery techniques for biologics, modern vaccine development, antibodies, and novel protein and peptide delivery. Overcoming the issue of the role of biologics in drug discovery and how to improve upon the length of time a drug remains effective in the body will also be addressed.

This year marks the 10th anniversary of Biotech 2010 – the annual joint bioscience symposium of BioNJ and Pennsylvania Bio. This symposium provides attendees with opportunities to network, learn from leading industry experts, share practical advice, and meet with potential partners.

Attendees will participate in six tracks, including Communications & Public Affairs; Finance; Growth Strategies for Bioscience Companies; Hot Topics in Business; Hot Topics in Science; and Medical Device, Diagnostics, & Drug Delivery.

Other highlights of Biotech 2010 include Company Presentations, enhanced Partnering sessions for one-on-one meetings, an Exhibit Hall, an Innovation Corridor, dynamic Plenary Sessions, and unparalleled networking opportunities.

BioNetwork now in its 8^th year, is a 3 day partnering event for Biotech and Pharmaceutical companies that facilitates partnering conversations through 1:1 meetings and extended networking activities. Every year, this event brings together executives from Business Development, Strategic Alliances, and Licensing to discuss the substantive issues occurring in the pharmaceutical industry. BioNetwork has become one of the top partnering events for Pharma and Biotech companies. The intimate, informal setting of BioNetwork allows all attendees to interact with one another and makes networking easier for attendees – if there is someone at BioNetwork that you want to meet, you will meet them. For more information about the event, please visit http://www.bionetworkus.com.

Register now and receive 25% off your registration with booking code 10386XN71CL.

The Georgia Bio Life Sciences Summit, October 28, 2010, in Atlanta, will feature 40 national and international speakers. Keynotes include Bernie Marcus, Co-Founder of The Home Depot, Inc., and Chairman of the Board of The Marcus Foundation; G. Steven Burrill, a biotech investment visionary; Dr. Michael Rosenblatt, Chief Medical Officer, Merck & Co; Dr. Vasant Narasimhan, Head of Vaccines North America, Novartis Vaccines and Diagnostics; Dr. Ricardo Azziz, President of Medical College of Georgia; and Dr. Michael Rosenberg, President & CEO of The Task Force for Global Health. Georgia Bio also will honor Bernie and Billi Marcus for advancing medical innovation.

The 2010 Medical Innovation Summit welcomes CEOs, leading venture capitalists, entrepreneurs, clinicians and top government officials to Cleveland, OH for a 3 day world-class conference where leaders will learn about the latest innovations in obesity and diabetes. What can you expect? You'll get fresh intelligence from the most authoritative voices in business and science; you'll have a chance to hear and take part in smart, fast-moving debates on the hottest topics in the field. You'll have the opportunity to meet people like yourself with a passion for medical innovation and its potential to improve life for us all and you'll have the opportunity to see live surgical demonstrations by renowned Cleveland Clinic specialists.

For more information and to register, visit: http://www.ClevelandClinic.org/innovations/summit/

GTCbio's 8^th Annual Vaccines: All Things Considered Conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development including research, manufacturing, regulations, investment, and policy in a comfortable, interactive and friendly setting. The 8^th Vaccines: All Things Considered Conference brings together the top names in vaccinology from industry leaders like Merck, Novartis and many more, as well as from academia and the government for practical discussions of the future of our discipline. Don't miss this opportunity to take all things into consideration. We look forward to welcoming you into our discussions of all things vaccines!

This informative conference will provide an extensive look at the new changes and developments caused by the healthcare reform act, and what the healthcare industry and related areas are doing to adapt. Participants will have the opportunity to gain important information on how to work with the bodies that will have jurisdiction under implementing regulations, financial business models and case studies that are necessary to comply with reform, as well as hear perspectives from both side of the political spectrum. Come and join the major players in healthcare and learn how you can adapt in this challenging yet unique time.

The 16th annual BIO-Europe event will be the largest biotechnology partnering conference held in Europe. Over 2,500 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. BIO-Europe features the industry's most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify.

Hear from industry leaders on gaining comprehension of patient advocacy, payer and specialty pharmacy groups to access orphan drug populations. This conference comes at a pivotal time when product patents are coming to an end and companies are looking to replenish their pipelines. Attending this premier conference will give you the opportunity to discuss critical issues, such as the Orphan Drug Act, while benchmarking your market access techniques in order to enhance and grow existing orphan drug portfolios

BioPartnering China^™ (BPC) is your opportunity to access the innovation and partnering opportunities represented in China's rapidly-growing life science industry. BayHelix works with TVG to bring together the leaders of the Chinese life science industry to network with decision-makers from around the world at BPC 2010.

For more information and to register, visit: http://www.techvision.com/bpc/

The 2nd Annual OneMedForum, taking place during the healthcare finance community's largest gathering of the year, will bring together promising emerging healthcare and life science companies with strategic and venture investors focused on new technologies, emerging and micro cap public companies. Its unique format of specialized sessions will bring together CEOs and strategic investors involved in various sectors for focused networking. More than 60 of the most promising private and small public companies with market capitalizations below $500 million will be making presentations.

In its 13th year, Drug Delivery Partnerships is the global meeting place for the Drug Delivery Industry. Participants from the Pharma, Biotech, Specialty Pharma and Generic industries come together to seek the latest strategies, industry updates, and networking opportunities to help position their company for a successful partnership/collaboration.

Medical Devices 2009 Executive MindXchange - now in its fourteenth year - brings you a comprehensive and up-to-the-minute perspective of the industry, and an awareness of trends and market forces that will significantly alter the landscape of the industry. It will deliver strategies and best practices for growth, along with executive insight and success stories. For more information and to receive a $250 savings courtesy of Medical Device Daily, please visit www.frost.com/dev.

BIO-Europe Spring^®2009 is an essential event for anyone serious about partnering in the biotech industry. As the springtime counterpart of BIO-Europe, the conference encourages delegates to continue establishing and maintaining partnerships using EBD Group's industry acclaimed approach. Please visit http://www.ebdgroup.com/bes.

Partnerships are vital to your company's success.

If your goal is to raise money, find your next partner, or learn how to work effectively with your existing partners, BioNetwork East is an event that you and your team cannot afford to miss. Join the most influential business development, licensing and alliance management decision makers in today's pharmaceutical and biotech industry!

Visit www.BioNetworkEast.com and register with booking code 10840.003XN71 to get 15% off.

The only event that brings together workforce and industry professionals, featuring sessions to help you:

• Establish Biotechnology Training Programs
• Recruit and Develop Talent to Fill Critical Needs in the Biotechnology Industry
• Secure Biotechnology Industry Funding
• Enhance Workforce Development through Public-Private Partnerships

While many strategies and practices have been developed and refined throughout the past few years, the immunogenicity industry still faces additional challenges in unifying guidelines. Join us at the 10th Annual Immunogenicity for Biotherapeutics to hear regulatory updates and interact directly with white paper authors to help you discover solutions to implement in your lab. Participate in our open discussions and help the industry continue to standardize immunogenicity practices. Please mention code XP1438BWT for 15% off the standard registration!

Over the past few years, market forces have redefined the medical device industry. IBF and Lifescience Alley^™ present this conference as an annual gathering to unite the most active investors with entrepreneurs, managers, and strategic players from the medical device industry to network and exchange information on current/future trends, challenges, and areas of opportunity. The timely agenda sheds light on navigating the current medical device landscape. For a detailed agenda or to register, please visit the web site at http://www.medtechconference.com. To receive $150 discount off the general registration fee, enter discount code MTMDD9 when registering.

Do you lead others as effectively as you work individually? Do you motivate as effectively as you criticize? Can you influence informally, persuasively so that your organization benefits bully from your knowledge? Few scientists can. The May 18 - 19 Biotech Leadership Skills Seminar improves your understanding and performance of the communications and leadership tasks that matter most for productivity and innovation. Focusing on the special challenges and opportunities technical leaders face, the intense, dynamic program includes 360 surveys of each participant. You work with case material on the real situations and challenges you face everyday. To ensure that participants not only understand core concepts but apply program insights, the program includes follow up coaching.

Never Before Has Partnering and Licensing Been So Important.

The 2009 BIO International Convention travels to Atlanta, Georgia, May 18-21, 2009. Join 20,000 executives, investors, scientists, researchers, policy makers and journalists from around the world for strategic discussions on new business models and new opportunities in biotech. Access the expert knowledge and resources you need to meet the challenges of today's dynamic economy and to strengthen your business for tomorrow. Come together with the industry to explore collaborations that will deliver on the promise of biotech to heal, fuel, feed the world. Registration and Housing Now Open. convention.bio.org

The only event of its kind for Sales and Marketing Executives! This new conference is designed to help you understand that the fast-changing landscape represents a huge opportunity rather than a threat. Maximize the influence of your field force with innovative strategies to forge long term holistic relationships with your customer.

The Medical Device Manufacturers Association (MDMA) 2009 Annual Meeting will bring together executives from innovative medical technology companies and healthcare's most influential and respected decision makers. Plan to join us in our Nation's Capital for a meeting that stimulates new ideas, offers solutions and promotes innovation in the changing spectrum of medical technology. View the agenda and register today: http://www.medicaldevices.org/public/news/AnnualMeetin g2009.asp

EuroMedtech^™ brings together international decision makers from the device industry, convergent biotech and pharma industry, and finance and is the only event focused on helping companies forge partnerships across the entire medtech value chain. Using EBD Group s partneringONE^™ service, EuroMedtech enables executives to efficiently identify and meet with strategic partners that spur innovation and drive future profits. The conference also features 15-minute company presentations of the latest medtech innovations, an insightful program featuring industry leaders, and an exhibition.

EuroMedtech is an event of EBD Group, organizer of the world-class partnering conferences BIO-Europe, BIO-Europe Spring^® and BioPharm America^™. For more information, please visit our website at www.ebdgroup.com/emt.

Opal Events is pleased to present what promises to be the most important drug discovery conference in 2009! This conference will provide attendees with the opportunity to gain insight on ways to resolve drug discovery bottlenecks and produce more innovative, efficacious and safe drugs. Panelist discussions will cover topics such as the best practices to improve the drug discovery process, ways to obtain insights for an optimal screening library size to improve the efficacy of drug discovery and several other valuable drug discovery topics. Please visit http://www.opalevents.org.

Senior government experts tasked with building the country's biodefense and pandemic influenza capacity will share their strategic plans at the 7th annual Biodefense Vaccines & Therapeutics conference. The conference is the ideal venue to connect with senior government experts, learn about their strategic plans for expanding the market for CBRN and pandemic influenza medical countermeasures, how they will use newly granted authority to beef up the national s capabilities for advanced development and manufacturing, and how the Administration will work with various stakeholders to leverage the developing biodefense infrastructure to deal with the growing threat of emerging infectious diseases around the world.

VIBevents' Laboratory Data Management conference, being held on 16 and 17 June 2009 in Munich, Germany, will bring experts from the pharmaceutical and biotech industry together to discuss practical strategies for improving your data management processes. From managing the ELNs and LIMS interface and effective data mining techniques, to interoperability, standardisation and archiving, this event will provide you with the latest approaches to driving lab efficiency and enhancing knowledge across the organisation. Don't miss the latest updates, networking opportunities, and strategies delivered and designed for your pharmaceutical and biotech needs. Visit http://www.vibevents.com/pharma/laboratorydata/register.ht m to register.

For this 13th annual meeting of the Allicense conference, we will examine the best practices and most innovative approaches for forging the alliances that bridge the gap between biomedical innovation and commercialization. This year we are pleased to welcome Corey Goodman, president of Pfizer's Biotherapeutics and Bioinnovation Center, Mikael Dolsten, president of Wyeth Research, and James C. Greenwood, president and CEO of the Biotechnology Industry Organization to the roster of industry leaders available to the attendees of Allicense 2009.

Registration includes conference sessions on June 17 - 18 plus continental breakfast & lunch on both days and admission to the Breakthrough Alliance Awards Dinner.

From the producers of the annual, industry-known Drug and Medical Device Litigation Conference, ACI is pleased to offer it's 3rd Annual Drug and Medical Device On Trial. For the past 13 years, drug and medical device litigators from across the country have relied on ACI to provide them with the most cutting edge insights on issues currently being litigated within their industry. The trial skills companion to this annual event, Drug and Med On Trial, provides the ultimate trial skills demonstration for pharmaceutical and device manufacturers and their counsel. Drawn from one central adverse event fact pattern and updated this year to reflect emerging issues in drug and device product liability litigation, including off label promotion and DTC advertising, this year's installment will feature in-house Co-Chairs from Eli Lilly and Medtronic, as well as an ALL IN-HOUSE Roundtable Discussion on Preparing and Selecting the Right Witness to Testify and the top defense litigators in the country, who are in the trenches, making news and setting precedent, defending the top drug and device manufacturers in the world. For more information, or to register, please visit: http://www.americanconference.com/mocktrial.htm

In response to industry demand, VIBevents is proud to announce the launch of the industry's first virtual clinical trials event, http://www.clinicaltrialsarena.com/index.html, which will bring together the leading decision makers within the pharma and biotech industries.

A total of three conference streams will provide delegates with the opportunity to attend the sessions most relevant to their specific business challenges including:

• Clinical Trial Supply
• Outsourcing Clinical Trials
• e-Clinical Trials

Designed specifically for Senior Executives in Clinical Trial Supply, Logistics and Clinical Operations, each conference programme lasts two days and is a unique opportunity to learn from leading experts and network with your peers without even having to leave the office! Visit http://www.clinicaltrialsarena.com/register.htm to register!

Salvo brings to you the Global Pharmaceutical Fraud & Anti-Counterfeiting Conference that features presentations on global strategy to fight counterfeiting. By attending this conference, you will understand the full fraud and counterfeiting threats to the global pharmaceutical industry as well as difficulties in dealing with this crime, current regulations, strategies, solutions and technologies for your success. Book now and save up to SGD700 off the regular price!

Guaranteeing that medical devices hit the market on time is challenging for newcomers as well as for established producers in China and the State Food and Drug Administration is enforcing stringent regulations and strengthening registration and safety surveillance. Consequently, producers must know how the registration procedure can be accelerated, how successful and responsible trials should be conducted and how the SFDA's safety requirements are monitored. With eminent speakers from regulatory departments, investment companies, hospitals of Grade III Level A, leading manufacturers and other industry stakeholders, this event will address these questions while delivering the most informative and influential gathering for the medical device industry.

DON'T BE THE NEXT TARGET OF OFF-LABEL PROMOTION CLAIMS!

Off-label promotion is one the biggest current triggers of government scrutiny in the pharmaceutical industry. Being aware of the current case law and guidelines that regulate and govern off-label communications is the bare minimum you must do. To manage such communications with confidence and mitigate potential liability, you must implement and monitor proper compliance and training programs and be ready to defend against any investigation or claim.

Don't miss this opportunity to answer your pressing questions and obtain the information you need from the leading experts in the field, as you network with your peers and colleagues from across the country. For more information, visit: www.americanconference.com/OffLabel

The Global Congress on Comparator Studies provides pharmaceutical and biotech executives the tool set required to establish a comprehensive strategy for sourcing comparators and overcoming regulatory challenges. This is the premier event offering in-depth insights into the logistical, regulatory and quality-related challenges surrounding comparator studies.

ACI's FDA Boot Camp – Chicago Edition – is THE ultimate basic training for products liability and patent lawyers on the subject of FDA regulatory law. Featuring a Who's Who of the nation's Food and Drug bar, this conference will provide you with a comprehensive overview of the basics of FDA law and regulation so that you can be the best life sciences products litigator or patent attorney you can be, while also developing a greater securities and investment expertise in your field. Attendees of this event will leave the conference having mastered the basics of the approval process for drugs, biologics and devices; developed a practical working knowledge of clinical trials for drugs and biologics; as well as the protocols of adverse events monitoring, product withdrawals, and recalls; Also, for in-depth discussion of issues relevant specifically to patent attorneys and products litigators, there will be two special tracks on advanced life cycle considerations and post-approval marketing guidance, along with a three session Focus on Medical Devices and a Product Liability Master Class on Drug and Medical Device Preemption. For more information, or to register, please visit: www.AmericanConference.com/FDABootCampChi

The Pharma CI Conference & Exhibition is the best and largest gathering of pharmaceutical competitive intelligence professionals! This is the industry's gold standard for senior level pharma, biotech, and medical device professionals who are seeking the latest in competitive intelligence/business intelligence to gain a competitive advantage.

Year after year, it's proven to be the premier event for participants to network with the industry's luminaries, and gain insight from cutting edge speakers who are ahead of the curve. The Pharma CI Conference will be held September 15-16, 2009 at the Sheraton Parsippany Hotel, New Jersey. For more information, please visit www.pharmaciconference.com.

BioPharm America ^™ is where biotech industry partnerships get started. Meet one-to-one with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE^™, the world's leading partnering system for the life science industry, BioPharm America is the only event in North America based on the same proven formula as EBD Group's acclaimed European events BIO-Europe and BIO-Europe Spring.

This must-attend one day interactive workshop provides CEOs and senior medical technology executives with a practical perspective on managing the key issues that directly impact successful product commercialization. Industry experts will address attracting and securing funding, recent developments at FDA, navigating reimbursement challenges, protecting and licensing IP and much more. In addition, speakers discuss managing these key elements as a company plans for the successful launch of new products and technologies.

The market for clinical diagnostics in China (both reagents and instruments) remains one of the most promising emerging markets in the world. Embracing the theme of Latest Domestics & Global Regulations & Standards, New Technologly Discovery & Diagnostics, 2009 In-Vitro Diagnostics Technology Congress will be your ideal one-stop solution to achieve competitive advantage in China IVD market from discovery, regulatory, commercialization to diagnostics. For more event information, please visit http://www.ivdtechcongress.com/.

The Vaccines Development Forum, created by and for the nation's leading vaccine development experts, is much more than a conference! It's a customized experience providing you the tools to innovate and expedite the development of profitable vaccines.

Why you MUST attend this event:

Pharmaceutical and biotech companies need to unlock the most efficient ways to develop stable, innovative, world-urgent and consumer-friendly vaccines to be a key player in the vaccine market.

The global demand and the potential for vaccine profitability continues to skyrocket, bringing an estimated thirty billion dollars in revenue by 2012. By developing your own vaccines your company can get their share of this profitability. Please mention code XP1433BWT for 15% off the standard registration!

The bar has been raised! There is great potential in the Asian market for regionally-based OTC manufacturers with strong marketing divisions, however companies must be able to manage the risks and build strategic relationships with key stakeholders. The Asia Business Forum presents OTC Pharma Asia, a 2-day conference that aims to capitalize on new market development and build a sustainable growth strategy for the pharmaceutical industry. This event will be beneficial for OTC drug manufacturers, distributors and retailers to keep up with the market dynamics and consumer's attitude towards OTC medications. Advance into the battle and be your company's troop of highly skilled OTC professionals.

The 2009 Medical Innovation Summit welcomes CEOs, leading venture capitalists, entrepreneurs, clinicians and top government officials to Cleveland, OH for a 3 day world-class conference where leaders will learn about the latest innovations in cancer therapy, diagnostics and management. What can you expect? You'll get fresh intelligence from the most authoritative voices in business and science; you'll have a chance to hear and take part in smart, fast-moving debates on the hottest topics in the field such as contemporary cancer treatments and the revolution in radiotherapy technology; you'll have the opportunity to meet people like yourself with a passion for medical innovation and its potential to improve life for us all and you'll have the opportunity to see live surgical demonstrations by renowned Cleveland Clinic specialists.

For details and to register: www.ClevelandClinic.org/innovations/summit

BioNetwork 2009 is a productive and engaging forum, giving business development, licensing and alliance management executives the direct opportunity to assess potential partnerships, evaluate developing therapeutic compounds and learn creative strategies to strengthen alliances. Register now and receive a $300 discount with booking code 10386004XZ515.

AdvaMed 2009 is the premier MedTech conference for business leaders, entrepreneurs, policymakers, media, financiers, and other industry stakeholders from around the world. In its second year, AdvaMed 2008 attracted 1,400 industry leaders including 500+ CEOs, Presidents and C-level executives.

On behalf of American Conference Institute, we look forward to welcoming you to Financing Solutions and Strategies for Life Sciences in New York this October. With many companies facing a funding crisis, the need for an expert forum on finding solutions to the credit gap and bringing together investors and corporate stakeholders to explore different financial models has never been greater.

The 7th Annual Clinical Trial Supply conference gives you the opportunity to network and discuss your strategies with a wealth of representatives from the major manufacturers. Through in-depth presentations and interactive roundtable discussions you will discover cost effective strategies to improve your clinical supply operations for saving cost, time and resources. This event is free to attend for biotech/pharma manufacturers Vice Presidents/Directors.

Register now at http://www.clinicaltrialsevents.com/eastcoast2009/regis ter.htm to reserve your FREE* place at the event. Remember to reference code BW.

The event will feature 50 leading speakers who will assess the prospects for industrial biotechnology and biobased products in Europe. It will commence with 2 parallel pre-conference seminars, followed by 2-day conference featuring plenary sessions, 3 afternoon tracks and OECD workshop as well as an exhibition. EFIB 2009 will be supported by adjoining events taking place in Lisbon during the same week, such as APBio's 4th annual Biomeet, Biobased Products Advisory Group meeting and the BIOCANT Site Visit. For more information, please log on to www.efibforum.com.

The BIO Investor Forum is a national investor forum exploring investment trends and opportunities in life sciences. Hear presentations from over 110 late-stage private and emerging public companies you won t see at other investor conferences. Meet one-on-one with new and current investors, analysts, and partnering companies. Gain insights from expert physicians, analysts, and company scientific officers at candid therapeutic and business panels. For more information on the latest program and an up-to-date list of presenting companies and investors, visit the BIO Investor Forum Web site.

The 15th annual BIO-Europe event is the world's largest dedicated biotechnology partnering conference. Over 2,500 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. BIO-Europe features the industry's most advanced web-based partnering system, enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.

In its ninth year, Biotech 2009 is the annual joint symposium of BioNJ and Pennsylvania Bio. It is designed to advance the growth and development of the bioscience industry in the Mid-Atlantic region. Top bioscience leaders will be at Biotech 2009 to network, connect with potential partners, share business strategies, and learn from their peers.

It will feature panel discussions on topics such as communications; drug delivery, device, and diagnostics; finance; growth strategies; hot topics in business, hot topics in science; and regulatory. It will also feature plenary sessions, renowned keynote speakers, Partnering sessions, an Innovation Corridor, and an Exhibit Hall.

The Project and Portfolio Management for Pharmaceuticals event will provide you with practical approaches to managing pharmaceutical industry projects. The conference will feature methodology specifically designed to help pharmaceuticals discover the importance of project, program and portfolio management in the drug development process, define and plan major organizational projects, track and manage pharmaceutical projects with greater accuracy, cut costs of developing new products, master the process of closing and executing programs, and visualize and plan project activities using a work breakdown structure.

Supported by China Pharmaceutical Association, Federation of Asian Biotechnology Association, Development Center of Biotechnology of Taiwan and Japan Biotechnology Association, China BioPharma Congress is the leading annual event designed to gather 400-500 executives representing bio pharmas, biotechs, CRO/CMOs, VC investors and equipment & technology providers etc to gather together for networking, discussing and seeking future business cooperation opportunities in China's biopharma industry.

China BioPharma Congress 2009 is featured with Asian government's speech on regulation updates, big pharma's panel discussion on new expanding strategy in Asia, PE/VC investors' panel on bio financing, 20 promising drug pipelines showcasing etc. For more information, please visit http://www.opplandcorp.com/BioPharma.

Announcing the return of the Premiere meeting in Innovations in Cardiovascular Interventions! The 2009 ICI Meeting is set to take place December 6-8, 2009, and is a continuation of the series of international conferences in interventional cardiology held in Israel since 1995, which have helped shape Israel as a leading force in innovative technology in this field. ICI 2009 will be held in collaboration with the Cardiovascular Research Foundation (CRF) and will focus on innovative technology and therapies.

The program will highlight numerous hot topics including new devices for trancatheter therapeutics, drug eluting stents, novel molecular therapeutics, vascular molecular biology, restenosis solutions, adjunctive drug therapy, carotid and valvular interventions, heart failure interventions and navigational and guidance percutaneous technologies. Included will be emerging technology sessions, industry-academia discussions, and a review of the regulatory aspects of new devices. Thematic live case demonstrations and clinical overviews on specific topics with an emphasis on future perspectives will be presented by leading international experts.

Plan to be with us!

Now in its 14th year, ACI's DRUG AND MEDICAL DEVICE LITIGATION is regarded as THE must-attend industry event. Not only is the conference a gathering of the who's who in product liability litigation, but our faculty of distinguished in-house and outside counsel and renowned federal and state jurists will provide practical insights and tactics for overcoming the litigation challenges faced by drug and device manufacturers. This year's conference will take place at the Millennium Broadway Hotel on December 8-10 in New York City. For more information, please visit us online: www.drugandmed.com.com

Based on the success of the 1st China International Pharmaceutical Summit, this year's summit will explore Chinese vaccine market situation and recently released regulations. The summit is aimed at providing a communication platform for all the delegates to exchange ideas, to find solutions to current job challenges, and to engage in networking opportunities.

Distinguished speakers from China central government and world-leading companies will share with the attendees their precious experience and opinions in China's vaccine industry. Best distribution and packaging strategies will be analyzed, shared and updated. In addition, the high profile event will keep you advance in novel vaccine and technology innovation.

This event will provide essential perspectives from both industry, regulatory and scientific perspectives in terms of what are the factors preventing biologics from progressing further in development and the vital elements of a successful early stage strategy for biologic studies. Attendees will achieve an advanced understanding of how to incorporate the specific biologic requirements into the strategic & operational planning for an early phase clinical trial that provides the best opportunity to save time, reduce risk, reduce costs and maximise product value.

Why attend?

Meet experts directly involved in biologic trial design and implementation
Learn about the specific regulatory guidance and level of proof required to satisfy the governing bodies.
Understand the perspectives of all stakeholder involved, i.e. regulators, sponsors, CROs, SMOs, central labs and experienced biologic investigators.
Come to benchmark, share experience and help to develop a best-practice approach to biologic clinical development.
Build stronger relationships upon a better understanding of the challenges faced by each group, who are all vital to the planning and implementation of the study.

To request the full agenda please follow the link:

https://www.nextle velpharma.com/events/request_agenda

The 3nd Annual OneMedForum will take place January 12th,13th, and 14th in San Francisco during the healthcare finance community's largest gathering of the year. The Forum provides an opportunity for the most promising emerging healthcare and life science companies to present and interact with a diverse group of global investors and partners. The 2010 event will feature Public and Private Company tracks and a session on Healthcare IT and the impact of reform and opportunities related to the stimulus package.

BioPartnering North America^™(BPN) brings together decision-makers from leading biotechnology, pharmaceutical and investment companies and features company presentations, pre-scheduled face-to-face partnering meetings, expert panels and workshops, and 3 days of networking opportunities.

BPN is proven to expand your network and connect your company with The Global Life Science Network^™. Year after year, BPN has proven to be one of the most valuable meetings to expand business connections. Our sponsors and presenters know that they are guaranteed to access a high-profile network of potential clients and in 2010 those clients are critical!

For over 25 years Informex has been North America s leading trade fair for companies dedicated to higher value chemistry. The show began in 1983 with a need to support companies that wanted new ways to produce cutting-edge chemicals, more efficiently, and with greater reliance on the expertise of fine and specialty chemical producers. Today s pharmaceutical innovators, agrochemical product makers, electronic materials producers and other manufacturers that come to Informex find what they need for business success, mainly new ideas that make a difference, and qualified companies with production assets that can make those ideas a reality.

This conference convenes 11 leading health care professionals to showcase how to apply and integrate important, new technology enhancements in the hospital providing perspectives from the payor and provider side. Specifically, they will show you how to increase cost savings, improve workflow efficiency and improve patient outcomes.

BIO-Europe Spring^® is the springtime counterpart to EBD Group's flagship conference, BIO-Europe. BIO-Europe Spring continues the tradition of providing life science companies with high caliber partnering opportunities.

Featuring EBD Group's sophisticated, web-based partnering system, partneringONE^®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative start-ups.

At BIO-Europe Spring in Milan in 2009, 1,845 licensing opportunities were posted by over 1,500 top level executives (+13% over 2008) who participated in 7,104 scheduled one-to-one meetings (+21% over 2008).

Over 25 years' of expertise have led Management Forum to be one of the most respected training providers in the UK. Providing high quality and in-depth seminars for professionals, Management Forum never fails to deliver. Now as part of our biotechnology series we invite you to attend The Regulation of rDNA Technology Derived Products' on the 11th March 2010, London. Attendees will receive an update on the technical aspects of the regulation of rDNA derived medicinal products, will improve their knowledge of the differences in the regulations between rDNA and conventional small molecule drugs, and will gain an invaluable opportunity to share experiences with other professionals and experts from across Europe.

Learn how to grow and retain talent, respond to the changing healthcare environment and sustain high growth at this year's sales and marketing meeting place for the medical device industry. Hear expert speakers from the likes of Boston Scientific, Medtronic, DePuy (a J&J company), Stryker, Covidien, Hospira and more.
Speakers will lead discussions on a variety of topics such as future-proofing your European go-to-market strategy, the importance of sales force effectiveness in a price and quality-sensitive market & how to implement your value proposition through your sales teams in this 2-day programme.

This interactive training event features methodology specifically designed to help pharmaceuticals and professionals from FDA regulated industries: Define and Plan Major Organizational Projects | Track and Manage Projects with Greater Accuracy | Cut the Costs of Developing New Products | Master the Process of Closing and Executing Programs | Visualize and Plan Project Activities Using a Work Breakdown Structure

Attend this event and discover practical approaches to managing pharmaceutical projects that dramatically increase results. Learn more or register today by visiting www.ASMIweb.com/Pharm

This Drug and Medical Device Litigation Conference builds on our last five successful events, providing timely, best-practices advice to corporate counsel in an industry under attack. Responding to market demand, this event offers fresh insights into discrete litigation issues; taking a more advanced approach to specific areas of contention, rather than walking corporate counsel through the litigation process. The Conference also addresses key litigation prevention and regulatory compliance strategies.

Now in its 11th year, Immunogenicity for Biotherapeutics is THE longest running and THE largest event designed by and for the community of scientists driving progress and innovation in immunogenicity studies. The industry's leading experts and scientists gather annually to discuss updates on emerging regulatory guidances, industry white papers, and exchange novel case studies and technology dedicated to drive forward the science , as well as expedite discovering solutions for the top immunogenicity challenges.

Audience Profile

Directors, Scientists, Research Associates, and Managers in Pharmaceutical, and Biotechnology companies working in the following functional areas: Immunology, Biotherapeutics, Immunotherapeutics, Analytical Development, Bioanalytical Development, Biopharmaceuticals, Preclinical Development, Molecular and Cell Biology, Antibody Engineering, and Pharmaceutical Research and Development.

Following on the success of Regulatory Challenges in Pharmaceutical Market Asia Conferences, Asia Business Forum brings you once again the industry's largest gathering of pharma executives and regulators to deliver timely information and discuss current initiatives and future laws on regulatory affairs that could benefit your business today! Through a series of presentations and interactive discussions covering key issues on drug registration, licensing, labeling & packaging, pricing & reimbursement, intellectual property, patent protection and harmonization of standards, participants of this year's PHARMACEUTICAL REGULATORY AFFAIRS & COMPLIANCE will gain better insights and share hands-on experiences with more pharma companies who have effectively and profitably incorporated regulatory strategy into their business strategy.

Join us at the 2010 BIO International Convention in Chicago from May 3-6, 2010 at McCormick place for key networking and partnering opportunities, and insights and inspiration on major industry trends.

The Convention offers biotech professionals the opportunity to fulfill the biotechnology promise of helping to heal, fuel and feed the world – featuring the BIO Business forum and all new BIOPark in the BIO Exhibition – mimicking a true biotech park.

Network with 15,000 leaders to discuss the business of biotech. Access the expert knowledge and partnering resources you need. Register today at http://convention.bio.org/

CBI and BIOON.COM have joined hands to present 2010 IVD Summit. Scientific, pragmatic, authoritative and up-to-date expertise and technologies will be shared at this conference. The participants will have great opportunities to network with one another, and get a thorough update about the policies and market. Cases will be studed to demonstrate how cutting-edge technologies have been turned into commercial success.

With increasing regulatory hurdles, medical device start-ups need to adopt new strategies to accelerate the time to market. This year's conference will focus on 'Navigating the Changing Landscape' with first hand perspectives and case-studies. International Business Forum and LifeScience Alley co-present this conference each year as a central gathering place for the leading MedTech VCs, CEOs, Corporates, and Investment Bankers to facilitate deal flow, share information, address concerns and explore new opportunities together. Attendance will be limited this year to the first 300 registrants to guarantee the optimum networking experience.

Health Care Reform: How do you sell in the new compliance environment? With 10 VP speaker insights, and 200 thought-leading attendees - this is the only event of its kind... we will demonstrate how to articulate your corporate value proposition to a wider audience.

Luis Abudo VP, Sales & Marketing, Stryker, Bryce Klontz Director, US Marketing, Covidien & Jeff Duchemin VP Sales, BD will be opening the meeting with a panel session discussing challenges in the adoption of new technologies in the current US healthcare environment. ZS associates will be heading a 90 minute interactive workshop to develop Advanced Sales Force Design Concepts.

The 13th Annual Software Design for Medical Devices taking place May 24-26, 2010 in San Diego, CA will provide you with thought-provoking and invaluable instruction for you to bring back to your software teams to facilitate strategic plans for developing quality devices on time.

Do not miss this opportunity to benchmark against other industry experts including Medrtonic, Abbott, CardioNet, U.S Genomics, GE Healthcare, St. Jude Medical and many more. Benefit as they present on successful FDA 510(k) submissions and resolutions related to changes in the Medical Device Directive.

C21 BioVentures^™(C21) is the leading conference where early stage innovators, investors and pharma partners come together to do the deals that make 2010 the year of global partnering.

C21 features private company presentations, pre-scheduled face-to-face partnering meetings, expert panels, workshops and three days of networking opportunities at an intimate world-class resort and spa. Register for C21 and connect your company with The Global Life Science Network^™.

For more information and to register, visit: http://www.techvision.com/c21/index.php?src=bioworld

To help promote the discovery of ocular disease and drug devleopment, GTCbio is bringing together leading scientists, researchers, and experts to discuss the latest research available in combating age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, uveitis and other eye diseases at the Ocular Diseases & Drug Discovery conference.

Speakers include keynote speakers Stephen Tsang of Columbia University and Meagan McLaughlin of GlaxoSmithKline, and individuals from Pfizer, Harvard University, Genzyme, NIH and other distinguished organizations in the field.

Registration discounts are available for those who register before April 27th, as well as those who register as a group.

This year's conference will bring together leaders from academia and industry to provide a better understanding of kinase activities and some solutions to the challenges associated with them. It will explore current drug design strategies to overcome issues such as pathway crosstalk, drug resistance and others.

Speakers include keynote speaker William C. Shakespeare, Ph.D., Vice President of Drug Discovery at ARIAD Pharmaceuticals and individuals from Hoffmann-La Roche, AstraZeneca, Pfizer, GlaxoSmithKline, Genentech, Bristol-Myers Squibb, Merck, Wyeth and other distinguished organizations.

Registration discounts are available for those who register before April 27th, as well as those who register as a group.

This forum provides cutting-edge information on developments in all areas of stem cell research including the biology, medicine, applications, regulations, and the business of Stem Cells. The conference will review recent developments in policies regarding funding for Stem Cell Research.

Speakers for this year include keynote speaker Rudolf Jaenisch, Ph. D., founder of the Whitehead Institute, featured speaker Katy Spink, Vice President of operations for Geron, and individuals from Genzyme, Columbia University, NIH, Duke University, Pfizer, and other distinguished organizations.

Registration discounts are available for those who register before April 27th, as well as those that register as a group.

EuroMedtech^™ is the annual medical technology partnering conference that provides unparalleled opportunities for collaboration among medtech decision makers. EuroMedtech attracts companies from all parts of the advanced medical technology industry, from those serving mainline therapeutic categories such as orthopedics and cardiovascular, through diagnostics, imaging and telemedicine to those involved in platform technologies such as biomaterials and regenerative medicine. Also attending are companies serving the industry, such as manufacturers, law firms, CROs and distributors. The event features EBD Group's sophisticated, web-based partnering system, partneringONE^®, the leading life science conference networking solution that enables delegates to efficiently identify potential partners and pre-arrange one-to-one meetings.

American Conference Institute s Medical Device Pricing and Reimbursement conference will be held on June 15^th and 16^th, 2010 in Chicago. The health care sector and government pricing of medical devices is in a state of flux, making it more important than ever to attend this industry event to learn how to develop an effective pricing and reimbursement strategy. The conference will feature an expert faculty including in-house experts from Covidien, Johnson & Johnson, Medtronic, Synthes, Xoft, Inc. and Zimmer.

As a subscriber to MDD you are entitled to a special registration price of $1775 ($200 off the standard price). Be sure to use discount code SP1 . Call 1-888-224-2480, fax your registration form to 1-877-927-1563, or register online at www.AmericanConference.com/devicepricing.

C5's 9th Annual Conference on Maximising Pharmaceutical Patent Lifecycles brings you an outstanding faculty from Europe and the US including The European Patent Office, Novartis, Astex Therapeutics, Merck & Co Inc.(US), Merck KGaA (Germany), Oxford Nanopore Technologies Ltd. (UK) and Vertex (UK), this conference will provide you with the most up to date information on how to manage and extend the exclusivity of your patent protected product.

Don't delay, register today by calling +44 (0) 20 7878 6888, by faxing your registration form to +44(0) 20 7878 6896 or by registering online at www.c5-online.com/pple.